As ECT2 showed important roles in affecting the clinical outcome, tumor stage, grade, and immune cell infiltration, we investigated the molecular interactions of ECT2, where two proteins, namely RACGAP1 and KIF23, were common ones in the two lists of “ECT2-interacting” and “ECT2-correlated” proteins. This evidence concerns the gene RACGAP1 and neoplasm.